Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2017

Apr 10, 2017

29745_dirs_2017-04-10_677617c3-a99e-4b15-9928-84da122cf56c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-04-01

Reporting Person: Norton Johna (Senior VP, Global Quality)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 14493 Direct
Common Stock 361 Indirect
Common Stock 1574 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Unit $ 2018-11-03 Common Stock (3133.0) Direct
Restricted Stock Unit $ Common Stock (193.0) Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: The Restricted Stock Units vest in three equal annual installments on February 16, 2018, 2019, and 2020.